Table 3. Mean value during the deactivation period (m ₂): MC.

(scale: 10−5 µM)
Subs.	Ch.1	Ch.2	Ch.3	Ch.4	Ch.5	Ch.6	Ch.7	Ch.8	Ch.9	Ch.10
1	6.71	−7.11	−3.27	−1.39	1.69	4.39	1.11	−0.69	4.69	−4.67
2	−9.72	1.31	−2.67	−6.17	4.83	0.96	−0.76	0.67	−5.48	1.77
3	−4.76	1.11	−11.34	−4.13	−3.80	−1.62	0.00	−2.01	2.04	3.77
4	0.54	−5.33	1.99	−3.32	−8.76	0.04	−5.06	−1.83	−9.07	−4.98
5	−2.94	−7.18	0.82	1.76	−4.28	−9.85	−5.03	−0.68	−3.08	1.31
6	−9.53	−2.59	−5.22	1.06	−1.40	−11.33	4.15	−10.01	2.79	−1.16
7	−12.73	−6.12	−0.97	0.63	−1.74	−5.91	0.05	−7.13	−5.44	1.66
8	−1.20	−0.95	0.37	−1.57	−2.46	−1.76	1.20	−2.95	3.28	−4.38
9	−0.45	−1.49	−1.31	−3.18	4.83	−3.08	−1.78	−3.12	−2.40	−5.96
10	−5.51	−11.29	−3.45	1.76	−2.56	3.70	2.29	−4.08	−7.18	−8.89
11	−0.25	1.02	−2.77	−1.88	1.19	−7.57	1.64	−0.13	−2.82	0.57
12	−3.05	−5.75	−6.66	−11.21	−2.37	−11.32	0.07	−3.97	11.57	−3.98
13	−5.67	−5.58	−6.01	−2.74	−3.74	−14.56	3.26	−2.52	−0.08	−4.42
14	0.61	0.00	−0.49	2.14	−1.37	3.19	−0.72	−6.25	0.00	−2.71
15	−1.36	−1.56	0.00	−6.87	4.79	−7.83	−1.25	−11.09	2.34	−2.85
16	6.65	−0.99	3.15	−4.89	−3.61	0.00	−2.47	0.00	15.67	10.05
17	−0.69	−1.16	−8.64	0.00	1.87	−0.24	0.00	−2.81	−4.61	−0.14
18	3.66	−5.95	−5.58	−2.46	−1.54	−8.33	1.26	−9.32	−9.31	−10.0
19	−11.55	−12.30	−4.08	−3.24	3.69	2.48	−2.76	0.00	−0.81	2.02
Avg*	-2.70	-3.79	-2.95	-2.40	-0.78	-3.61	-0.25	-3.58	-0.42	-1.74
SD**	5.54	4.03	3.71	3.40	3.68	5.80	2.46	3.58	6.46	4.73

* The Avg row indicates the average value over 19 subjects.

** SD denotes standard deviation.